Literature DB >> 14579898

Natural history and clinical management of optic pathway glioma.

J Astrup1.   

Abstract

Twenty-five consecutive unselected patients with optic pathway glioma (OPG) were primarily observed and treated if progression was evident. Diagnosis was based on MRI. The natural history of the OPG disease was more indolent in 12 patients with neurofibromatosis 1 (NF1) than in the others, and regressions were commonly observed. Thirteen non-NF1 patients had larger rumours at diagnosis and more progressions. There were five intra-orbital optic nerve tumours (one with progression), 19 chiasmatic tumours (12 with progression) and one diffuse tumour. OPG emerges before the age of 7 years in NF1 patients, and in non-NF1 patients also in older patients including adults. Progressive intra-orbital OPGs are best treated by surgical resection. Progressive chiasmatic tumours are best treated by radiotherapy and respond well by marked regression. Exceptionally, exophytic chiasmatic tumours may be treated by chiasm preserving surgery.

Entities:  

Mesh:

Year:  2003        PMID: 14579898     DOI: 10.1080/02688690310001601216

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  33 in total

1.  Neurofibromatosis 1-associated optic pathway gliomas.

Authors:  Ben Shofty; Liat Ben Sira; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2020-06-11       Impact factor: 1.475

2.  Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?

Authors:  Kristian Aquilina; David J Daniels; Helen Spoudeas; Kim Phipps; Hoong-Wei Gan; Frederick A Boop
Journal:  Childs Nerv Syst       Date:  2015-08-16       Impact factor: 1.475

Review 3.  Pediatric low-grade gliomas.

Authors:  Angela J Sievert; Michael J Fisher
Journal:  J Child Neurol       Date:  2009-11       Impact factor: 1.987

4.  Suprasellar pilocytic astrocytoma: one national centre's experience.

Authors:  Tafadzwa Mandiwanza; Chandrasekaran Kaliaperumal; Ayman Khalil; Muhammad Sattar; Darach Crimmins; John Caird
Journal:  Childs Nerv Syst       Date:  2014-02-25       Impact factor: 1.475

5.  Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis.

Authors:  Michael J Fisher; Michael Loguidice; David H Gutmann; Robert Listernick; Rosalie E Ferner; Nicole J Ullrich; Roger J Packer; Uri Tabori; Robert O Hoffman; Simone L Ardern-Holmes; Trent R Hummel; Darren R Hargrave; Eric Bouffet; Joel Charrow; Larissa T Bilaniuk; Laura J Balcer; Grant T Liu
Journal:  Neuro Oncol       Date:  2012-04-03       Impact factor: 12.300

Review 6.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

7.  Assessment of chemotherapeutic response in children with proptosis due to optic nerve glioma.

Authors:  Roberto Jose Diaz; Suzanne Laughlin; Gary Nicolin; J Raymond Buncic; Eric Bouffet; Ute Bartels
Journal:  Childs Nerv Syst       Date:  2007-12-22       Impact factor: 1.475

Review 8.  Visual function tests including the role of optical coherence tomography in neurofibromatosis 1.

Authors:  Daphna Mezad-Koursh; Anat Bachar Zipori; Dinah Zur; Lior Degabli; Meital Ben-Dov; Ainat Klein
Journal:  Childs Nerv Syst       Date:  2020-08-04       Impact factor: 1.475

Review 9.  Update on the management of familial central nervous system tumor syndromes.

Authors:  Andreas F Hottinger; Yasmin Khakoo
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

10.  A case of neurofibromatosis 1 presenting with optic pathway glioma with an early onset and an aggressive course.

Authors:  Suma Ganesh; Archana Gupta; Manish Sharma; Sandeep Bhuttan
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.